27
H index
47
i10 index
3423
Citations
Frank Lichtenberg : Citation Profile
National Bureau of Economic Research (NBER) (30% share) | RESEARCH PRODUCTION: 87 Articles 89 Papers 13 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
43 years (1981 - 2024). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Frank Lichtenberg. | Is cited by:
| Cites to:
|
Main data
Where Frank Lichtenberg has published?
Recent works citing Frank Lichtenberg (2025 and 2024)
Year  | Title of citing document |
|---|---|
| 2024 | Should I stay or should I go? Effects of being acquired on employee outcomes: evidence from Brazil.. (2024). Matas, Liwski Joaqun. In: Asociación Argentina de Economía Política: Working Papers. RePEc:aep:anales:4740. Full description at Econpapers || Download paper |
| 2024 | . Full description at Econpapers || Download paper |
| 2025 | Recovering latent linkage structures and spillover effects with structural breaks in panel data models. (2025). Okui, Ryo ; Wang, Wendun ; Sun, Yutao. In: Papers. RePEc:arx:papers:2501.09517. Full description at Econpapers || Download paper |
| 2024 | How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies. (2024). Liebman, Eli ; Fernando, Lasanthi ; Dunn, Abe C. In: BEA Papers. RePEc:bea:papers:0132. Full description at Econpapers || Download paper |
| 2024 | Caveat emptor as an obstacle to business transfers: Effect of product line liability exceptions on acquisitions, entry, and exit. (2024). Xu, Wenjian ; Sivadasan, Jagadeesh ; Balasubramanian, Natarajan. In: Strategic Management Journal. RePEc:bla:stratm:v:45:y:2024:i:7:p:1300-1325. Full description at Econpapers || Download paper |
| 2024 | To leave or to stay: Digital economy development and migrant workers’ location. (2024). Wei, Xiahai ; Lou, Shiyan ; Yu, Lingzheng ; Wang, Jiannan. In: Journal of Asian Economics. RePEc:eee:asieco:v:94:y:2024:i:c:s1049007824000873. Full description at Econpapers || Download paper |
| 2024 | Foreign investors, firm level productivity, and European economic integration. (2024). Phylaktis, Kate ; Onay, Ceylan ; Muradoglu, Gulnur ; Bailey, Warren. In: Journal of Corporate Finance. RePEc:eee:corfin:v:85:y:2024:i:c:s0929119924000269. Full description at Econpapers || Download paper |
| 2024 | Reasons for M&A: A perspective from senior executives rural experiences- Evidence from Chinese private listed companies. (2024). He, Xiaogang ; Peng, Jinxia ; Xiao, Xiaohong. In: International Review of Financial Analysis. RePEc:eee:finana:v:93:y:2024:i:c:s1057521924001418. Full description at Econpapers || Download paper |
| 2024 | Political risk of green public procurement and firms green innovation. (2024). Liu, Chengxin ; Huang, Xiang ; Wang, Jiaxin ; Song, Zilong ; Sun, DI. In: Finance Research Letters. RePEc:eee:finlet:v:62:y:2024:i:pb:s1544612324002654. Full description at Econpapers || Download paper |
| 2024 | When banks become pure creditors: The effects of declining shareholding by Japanese banks on bank lending and firms’ risk-taking. (2024). Uesugi, Iichiro ; Ono, Arito ; Suzuki, Katsushi. In: Journal of Financial Stability. RePEc:eee:finsta:v:73:y:2024:i:c:s1572308924000792. Full description at Econpapers || Download paper |
| 2024 | The behavioral additionality of government research grants. (2024). Widmann, Rainer. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:93:y:2024:i:c:s0167718723001145. Full description at Econpapers || Download paper |
| 2024 | The nonlinear relationship between employee stock ownership plans and firm performance: Evidence from China. (2024). Dasilas, Apostolos. In: Journal of Business Research. RePEc:eee:jbrese:v:173:y:2024:i:c:s0148296323008299. Full description at Econpapers || Download paper |
| 2024 | The more, the better: The influence of overconfident CEOs on their firms’ digital orientation. (2024). Strese, Steffen ; Saesen, Julie ; Hedwig, Corinna Vera. In: Journal of Business Research. RePEc:eee:jbrese:v:183:y:2024:i:c:s0148296324003138. Full description at Econpapers || Download paper |
| 2024 | Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D. (2024). Hermosilla, Manuel. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629623001327. Full description at Econpapers || Download paper |
| 2024 | Growth gains from offshore outsourcing. (2024). Veeramani, C ; Marjit, Sugata ; Basu, Anwesha. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:46:y:2024:i:1:p:90-112. Full description at Econpapers || Download paper |
| 2024 | The impact of government procurement on green technological innovation: Evidence from manufacturing sector in china. (2024). Qiu, Yumin ; Liu, Xiaofeng ; Zhou, Wenxiang ; Miao, Haoran. In: Pacific-Basin Finance Journal. RePEc:eee:pacfin:v:86:y:2024:i:c:s0927538x24002087. Full description at Econpapers || Download paper |
| 2024 | Stock return volatility and financial distress: Moderating roles of ownership structure, managerial ability, and financial constraints. (2024). Nguyen, Manh Huu ; Barky, Walid ; van Nguyen, Phuc ; Huong, Giang Thi. In: International Review of Economics & Finance. RePEc:eee:reveco:v:91:y:2024:i:c:p:634-652. Full description at Econpapers || Download paper |
| 2024 | Evaluating the impact of OFDI on the growth quality of industrial firms: A dual-perspective analysis from China. (2024). Cai, Molly ; Kong, Qunxi ; Wang, Ziqi ; Peng, Dan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:1616-1627. Full description at Econpapers || Download paper |
| 2024 | University procurement-led innovation: Sources, procedures, and effects. Some field-study evidence. (2024). Patsali, Sofia. In: Technovation. RePEc:eee:techno:v:130:y:2024:i:c:s0166497223002122. Full description at Econpapers || Download paper |
| 2024 | Beyond funding: The moderating role of firms R&D human capital on government support and venture capital for regional innovation in China. (2024). Prevot, Frederic ; Edeh, Jude. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:203:y:2024:i:c:s0040162524001471. Full description at Econpapers || Download paper |
| 2024 | Do trade agreements contribute to the decline in labor share? Evidence from Latin American countries. (2024). Ruffo, Hernán ; Gonzalez-Rozada, Martin. In: World Development. RePEc:eee:wdevel:v:177:y:2024:i:c:s0305750x24000317. Full description at Econpapers || Download paper |
| 2024 | Does Quality Certification or Product Diversification Improve the Performance of Small and Medium Enterprises?. (2024). Nguyen, Van-Hoa ; Le, Duc-Niem. In: Sustainability. RePEc:gam:jsusta:v:16:y:2024:i:5:p:2023-:d:1348778. Full description at Econpapers || Download paper |
| 2024 | Is a College Education Still Enough? The IT-Labor Relationship with Education Level, Task Routineness, and Artificial Intelligence. (2024). Yao, Yuliang ; Peng, Gang ; Zhang, Dawei ; Browning, Tyson R. In: Information Systems Research. RePEc:inm:orisre:v:35:y:2024:i:3:p:992-1010. Full description at Econpapers || Download paper |
| 2025 | Ownership Changes and Firm Dynamics. (2025). Bruggemann, Bettina ; Mahone, Zachary L ; Palmer, Thomas. In: Department of Economics Working Papers. RePEc:mcm:deptwp:2025-03. Full description at Econpapers || Download paper |
| 2024 | Multifactor productivity growth enhancers across industries and countries: Firm-level evidence. (2024). Nakatani, Ryota. In: MPRA Paper. RePEc:pra:mprapa:120503. Full description at Econpapers || Download paper |
| 2025 | The National Civilized City campaign and corporate green innovation: evidence from a quasi-natural experiment in China. (2025). Xu, Wei ; Liu, Jiawei ; Zhou, Zhongsheng. In: The Annals of Regional Science. RePEc:spr:anresc:v:74:y:2025:i:1:d:10.1007_s00168-024-01333-7. Full description at Econpapers || Download paper |
| 2024 | Foreign capital inflows, exchange rates, and government stability. (2024). McCloud, Nadine ; Delgado, Michael S ; Jin, Man. In: Empirical Economics. RePEc:spr:empeco:v:66:y:2024:i:3:d:10.1007_s00181-023-02490-y. Full description at Econpapers || Download paper |
| 2024 | Understanding Labour Productivity Convergence: Empirical Evidence from South Asia. (2024). Ahmad, Sareer ; Ullah, Kifayat ; Mahmood, Tahir. In: The Indian Journal of Labour Economics. RePEc:spr:ijlaec:v:67:y:2024:i:4:d:10.1007_s41027-024-00543-z. Full description at Econpapers || Download paper |
| 2024 | Financial incentives and prescribing behavior in primary care. (2024). Herr, Annika ; Gravelle, Hugh ; Bodnar, Olivia ; Gutacker, Nils. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:696-713. Full description at Econpapers || Download paper |
| 2024 | Public procurement can hinder innovation. (2024). Strecke, Linus ; Pruefer, Malte ; Krieger, Bastian. In: ZEW Discussion Papers. RePEc:zbw:zewdip:287768. Full description at Econpapers || Download paper |
Works by Frank Lichtenberg:
| Year | Title | Type | Cited |
|---|---|---|---|
| 1998 | The Impact and Organization of Publicly-Funded Research and development in the European Community In: Annals of Economics and Statistics. [Full Text][Citation analysis] | article | 27 |
| 1997 | The Impact and Organization of Publicly-Funded Research and Development in the European Community.(1997) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 27 | paper | |
| 2005 | Are the More Educated More Likely to Use New Drugs? In: Annals of Economics and Statistics. [Full Text][Citation analysis] | article | 39 |
| 2010 | Are the More Educated More Likely to Use New Drugs?.(2010) In: NBER Chapters. [Citation analysis] This paper has nother version. Agregated cites: 39 | chapter | |
| 1984 | The Relationship between Federal Contract R&D and Company R&D. In: American Economic Review. [Citation analysis] | article | 83 |
| 1988 | The Private R&D Investment Response to Federal Design and Technical Competitions. In: American Economic Review. [Full Text][Citation analysis] | article | 112 |
| 1996 | Do (More and Better) Drugs Keep People Out of Hospitals? In: American Economic Review. [Full Text][Citation analysis] | article | 31 |
| 2007 | The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data In: American Economic Review. [Full Text][Citation analysis] | article | 16 |
| 1989 | Errors of Measurement in Output Deflators. In: Journal of Business & Economic Statistics. [Citation analysis] | article | 25 |
| 1986 | Errors of Measurement in Output Deflators.(1986) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 25 | paper | |
| 1987 | Productivity and Changes in Ownership of Manufactoring Plants In: Brookings Papers on Economic Activity. [Full Text][Citation analysis] | article | 94 |
| 2017 | The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia In: The Economic Record. [Full Text][Citation analysis] | article | 1 |
| 1989 | THE EFFECT OF CONTROL CHANGES ON THE PRODUCTIVITY OF U.S. MANUFACTURING PLANTS In: Journal of Applied Corporate Finance. [Full Text][Citation analysis] | article | 6 |
| 1987 | The Effect of Government Funding on Private Industrial Research and Development: A Re-assessment. In: Journal of Industrial Economics. [Full Text][Citation analysis] | article | 68 |
| 1989 | Contributions to Federal Election Campaigns by Government Contractors. In: Journal of Industrial Economics. [Full Text][Citation analysis] | article | 2 |
| 1988 | CONTRIBUTIONS TO FEDERAL ELECTION CAMPAIGNS BY GOVERNMENT CONTRACTORS.(1988) In: Columbia - Graduate School of Business. [Citation analysis] This paper has nother version. Agregated cites: 2 | paper | |
| 1998 | Computer Use and Productivity Growth in US Federal Government Agencies, 1987–92 In: Journal of Industrial Economics. [Full Text][Citation analysis] | article | 15 |
| 2010 | Pharmaceutical Price Discrimination and Social Welfare In: Capitalism and Society. [Full Text][Citation analysis] | article | 3 |
| 2008 | Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 1 |
| 2007 | Pharmaceutical Innovation and US Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data.(2007) In: NBER Chapters. [Citation analysis] This paper has nother version. Agregated cites: 1 | chapter | |
| 2010 | Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 3 |
| 2010 | Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia.(2010) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | paper | |
| 2013 | The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 13 |
| 2012 | The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files.(2012) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 13 | paper | |
| 2017 | The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004–2012 In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 0 |
| 2018 | The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 0 |
| 2019 | The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis.(2019) In: CESifo Working Paper Series. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2021 | The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998–2015 In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 0 |
| 2002 | The Effects of Medicare on Health Care Utilization and Outcomes In: Forum for Health Economics & Policy. [Full Text][Citation analysis] | article | 34 |
| 2002 | The Effects of Medicare on Health Care Utilization and Outcomes.(2002) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 34 | chapter | |
| 2018 | The Impact of New Drug Launches on Longevity Growth in Nine Middle Eastern and African Countries, 2007–2015 In: Review of Middle East Economics and Finance. [Full Text][Citation analysis] | article | 0 |
| 1989 | USING LINKED CENSUS R&D-LRD DATA TO ANALYZE THE EFFECT OF R&D INVESTMENT ON TOTAL FACTOR PRODUCTIVITY GROWTH In: Working Papers. [Full Text][Citation analysis] | paper | 5 |
| 1989 | The Effect Of Takeovers On The Employment And Wages Of Central-Office And Other Personnel In: Working Papers. [Full Text][Citation analysis] | paper | 8 |
| 1989 | THE EFFECT OF TAKEOVERS ON THE EMPLOYMENT AND WAGES OF CENTRAL-OFFICE AND OTHER PERSONNEL.(1989) In: Columbia - Graduate School of Business. [Citation analysis] This paper has nother version. Agregated cites: 8 | paper | |
| 1989 | The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel.(1989) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 8 | paper | |
| 1989 | The Effects Of Leveraged Buyouts On Productivity And Related Aspects Of Firm Behavior In: Working Papers. [Full Text][Citation analysis] | paper | 193 |
| 1990 | The effects of leveraged buyouts on productivity and related aspects of firm behavior.(1990) In: Journal of Financial Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 193 | article | |
| 1989 | The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior.(1989) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 193 | paper | |
| 1997 | The Allocation of Publicly-Funded Biomedical Research In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 16 |
| 2001 | The Allocation of Publicly Funded Biomedical Research.(2001) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 16 | chapter | |
| 1998 | The Allocation of Publicly-Funded Biomedical Research.(1998) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 16 | paper | |
| 2009 | Response to Baker and Fugh-Bermans Critique of my Paper, Why has Longevity Increased more in some States than in others? In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 1 |
| 2010 | The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 3 |
| 2012 | The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 2 |
| 2014 | The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data.(2014) In: Economics of Innovation and New Technology. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | article | |
| 2000 | The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 6 |
| 2001 | The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey.(2001) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2000 | Sources of U.S. Longevity Increase, 1960 -1997 In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 14 |
| 2002 | Sources of U.S. Longevity Increase, 1960-1997.(2002) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 14 | paper | |
| 2013 | The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2015 | The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.(2015) In: Social Science & Medicine. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | article | |
| 2015 | Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010 In: CESifo Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2015 | Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010.(2015) In: International Journal of the Economics of Business. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | article | |
| 1999 | Information technology and its impact on firm-level productivity: evidence from government and private data sources, 1977-1993 In: Canadian Journal of Economics. [Full Text][Citation analysis] | article | 58 |
| 2018 | The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries In: JODE - Journal of Demographic Economics. [Full Text][Citation analysis] | article | 2 |
| .() In: . [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | article | ||
| 2018 | The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | paper | |
| 2018 | The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | paper | |
| 2010 | Spurious correlation in estimation of the health production function: A note In: Economics Bulletin. [Full Text][Citation analysis] | article | 7 |
| 2009 | Spurious correlation in estimation of the health production function: A note.(2009) In: SOI - Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 7 | paper | |
| 1999 | Managerial ownership and firm performance: A re-examination using productivity measurement In: Journal of Corporate Finance. [Full Text][Citation analysis] | article | 71 |
| 1989 | IR & D project data and theories of R & D investment In: Journal of Economic Dynamics and Control. [Full Text][Citation analysis] | article | 1 |
| 1988 | IR&D Project Data and Theories of R&D Investment.(1988) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 1998 | International R&D spillovers: A comment In: European Economic Review. [Full Text][Citation analysis] | article | 218 |
| 1998 | International R&D spillovers comment.(1998) In: ULB Institutional Repository. [Citation analysis] This paper has nother version. Agregated cites: 218 | paper | |
| 2014 | The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009 In: Economics & Human Biology. [Full Text][Citation analysis] | article | 3 |
| 2003 | The effect of new drug approvals on HIV mortality in the US, 1987-1998 In: Economics & Human Biology. [Full Text][Citation analysis] | article | 3 |
| 2022 | The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries In: Economics & Human Biology. [Full Text][Citation analysis] | article | 0 |
| 1987 | Changing market opportunities and the structure of R & D investment : The case of energy In: Energy Economics. [Full Text][Citation analysis] | article | 2 |
| 1995 | Economics of defense R&D In: Handbook of Defense Economics. [Full Text][Citation analysis] | chapter | 20 |
| 2014 | The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010 In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2012 | Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization In: International Review of Law and Economics. [Full Text][Citation analysis] | article | 7 |
| 1994 | Ownership structure and corporate performance in Japan In: Japan and the World Economy. [Full Text][Citation analysis] | article | 78 |
| 1992 | Ownership Structure and Corporate Performance in Japan.(1992) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 78 | paper | |
| 1988 | The burden of government : , Stanford: Hoover Institution Press, 1986. x + 188 pp., $23.95 In: Journal of Comparative Economics. [Full Text][Citation analysis] | article | 0 |
| 1992 | Industrial de-diversification and its consequences for productivity In: Journal of Economic Behavior & Organization. [Full Text][Citation analysis] | article | 54 |
| 1990 | Industrial De-Diversification and Its Consequences for Productivity.(1990) In: Economics Working Paper Archive. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 54 | paper | |
| 1990 | Industrial De-Diversification and its Consequences for Productivity.(1990) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 54 | paper | |
| 1995 | Labour market institutions, liquidity constraints, and macroeconomic stability In: Journal of Economic Behavior & Organization. [Full Text][Citation analysis] | article | 0 |
| 1991 | Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability.(1991) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 1995 | Rejoinder to comment by Maarten Vendrik In: Journal of Economic Behavior & Organization. [Full Text][Citation analysis] | article | 0 |
| 1989 | How elastic is the governments demand for weapons? In: Journal of Public Economics. [Full Text][Citation analysis] | article | 4 |
| 1988 | HOW ELASTIC IS THE GOVERNMENTS DEMAND FOR WEAPONS?.(1988) In: Columbia - Graduate School of Business. [Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 1989 | How Elastic is the Governments Demand for Weapons?.(1989) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 2004 | Sources of U.S. longevity increase, 1960-2001 In: The Quarterly Review of Economics and Finance. [Full Text][Citation analysis] | article | 27 |
| 1986 | Energy prices and induced innovation In: Research Policy. [Full Text][Citation analysis] | article | 21 |
| 1990 | Issues in measuring industrial R&D In: Research Policy. [Full Text][Citation analysis] | article | 4 |
| 2010 | Pharmaceutical innovation and mortality in the United States, 1960-2000. A commentary on Schnittker and Karandinos In: Social Science & Medicine. [Full Text][Citation analysis] | article | 0 |
| 2013 | The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007 In: Social Science & Medicine. [Full Text][Citation analysis] | article | 1 |
| 2011 | The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007.(2011) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2022 | The impact of biomedical innovation on longevity and health In: Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2008 | Pharmaceutical innovation and the longevity of Australians: A first look In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 4 |
| 2008 | Pharmaceutical innovation and the longevity of Australians: a first look.(2008) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
| 2010 | The effect of drug vintage on survival: Micro evidence from Puerto Ricos Medicaid program In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 1 |
| 2004 | The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Ricos Medicaid Program.(2004) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2012 | The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 0 |
| 2012 | The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey.(2012) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2003 | The benefits to society of new drugs: a survey of the econometric evidence In: Proceedings. [Full Text][Citation analysis] | article | 2 |
| 1996 | The European Strategic Program for Research in Information Technologie (ESPRIT): An Ex-Post Analysis. In: Columbia - Graduate School of Business. [Citation analysis] | paper | 3 |
| 1996 | Computer Use and Productivity Growth in federal Government Agencies. In: Columbia - Graduate School of Business. [Citation analysis] | paper | 4 |
| 1996 | The Effect of New Political Administration on Federal Government Productivity and Employment. In: Columbia - Graduate School of Business. [Citation analysis] | paper | 1 |
| 1996 | The Effect of New Political Administration on Federal Government Productivity and Employment.(1996) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 1988 | GOVERNMENT SUBSIDIES TO PRIVATE MILITARY R&D INVESTMEN: DODS IR&D POLICY. In: Columbia - Graduate School of Business. [Citation analysis] | paper | 5 |
| 1988 | Government Subsidies to Private Military R&D Investment: DODs IR&D Policy.(1988) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 5 | paper | |
| 1988 | CROWDING OUT: THE IMPACT OF THE STRATEGIC DEFENSE INITIATIVE ON U.S. CIVILIAN R&D INVESTMENT AND INDUSTRIAL COMPETITIVENESS In: Columbia - Graduate School of Business. [Citation analysis] | paper | 0 |
| 2020 | Are patients more adherent to newer drugs? In: Health Care Management Science. [Full Text][Citation analysis] | article | 2 |
| 2011 | The quality of medical care, behavioral risk factors, and longevity growth In: International Journal of Health Economics and Management. [Full Text][Citation analysis] | article | 11 |
| 2009 | The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth.(2009) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 11 | paper | |
| 2015 | The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011 In: International Journal of Health Economics and Management. [Full Text][Citation analysis] | article | 5 |
| 2015 | The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011.(2015) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 5 | paper | |
| 2024 | Has pharmaceutical innovation reduced the average cost of U.S. health care episodes? In: International Journal of Health Economics and Management. [Full Text][Citation analysis] | article | 0 |
| 2005 | The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 In: International Journal of Health Economics and Management. [Full Text][Citation analysis] | article | 33 |
| 2003 | The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001.(2003) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 33 | paper | |
| 1996 | Book Reviews In: Journal of Economics. [Full Text][Citation analysis] | article | 0 |
| 1991 | The Managerial Response to Regulation of Financial Reporting for Segments of a Business Enterprise. In: Journal of Regulatory Economics. [Citation analysis] | article | 14 |
| 1989 | The Effects of Mergers on Prices, Costs, And Capacity Utilization in the U.S. Air Transportation Industry, 1970-84 In: Economics Working Paper Archive. [Full Text][Citation analysis] | paper | 0 |
| 1989 | The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84.(1989) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 2000 | The Impact of Hospital Quality-Related Practices on Health Outcomes In: Center for Policy Research Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 1984 | R&D and Productivity Growth at the Industry Level: Is There Still a Relationship? In: NBER Chapters. [Full Text][Citation analysis] | chapter | 126 |
| 2005 | Pharmaceutical Knowledge-Capital Accumulation and Longevity In: NBER Chapters. [Full Text][Citation analysis] | chapter | 3 |
| 2016 | The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis In: NBER Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2018 | The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger In: NBER Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 1981 | Training, Tenure, and Productivity In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 1982 | R and D and Productivity at the Industry Level: Is There Still a Relationship? In: NBER Working Papers. [Full Text][Citation analysis] | paper | 11 |
| 2004 | The Expanding Pharmaceutical Arsenal in the War on Cancer In: NBER Working Papers. [Full Text][Citation analysis] | paper | 11 |
| 2004 | The expanding pharmaceutical arsenal in the war on cancer.(2004) In: 2004 Meeting Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 11 | paper | |
| 2006 | The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2006 | The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data In: NBER Working Papers. [Full Text][Citation analysis] | paper | 5 |
| 2006 | Importation and Innovation In: NBER Working Papers. [Full Text][Citation analysis] | paper | 8 |
| 2007 | IMPORTATION AND INNOVATION.(2007) In: Economics of Innovation and New Technology. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 8 | article | |
| 2008 | Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2009 | Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country‐level data on 20 OECD countries, 1995–2003.(2009) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | article | |
| 2010 | Has medical innovation reduced cancer mortality? In: NBER Working Papers. [Full Text][Citation analysis] | paper | 12 |
| 2014 | Has Medical Innovation Reduced Cancer Mortality?.(2014) In: CESifo Economic Studies. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 12 | article | |
| 1985 | The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence In: NBER Working Papers. [Full Text][Citation analysis] | paper | 6 |
| 2012 | Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2013 | The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 1986 | Private Investment in R&D to Signal Ability to Perform Government Contracts In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2015 | Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients In: NBER Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2017 | The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2018 | The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality In: NBER Working Papers. [Full Text][Citation analysis] | paper | 4 |
| 2019 | The long-run impact of new medical ideas on cancer survival and mortality.(2019) In: Economics of Innovation and New Technology. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | article | |
| 2019 | How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 1988 | Technical Change, Learning, and Wages In: NBER Working Papers. [Full Text][Citation analysis] | paper | 5 |
| 1989 | The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data In: NBER Working Papers. [Full Text][Citation analysis] | paper | 179 |
| 1991 | The Impact of R&D Investment on Productivity--New Evidence Using Linked R&D-LRD Data..(1991) In: Economic Inquiry. [Citation analysis] This paper has nother version. Agregated cites: 179 | article | |
| 2022 | The Effects of Off-label Drug Use on Disability and Medical Expenditure In: NBER Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2022 | The effects of off-label drug use on disability and medical expenditure.(2022) In: Ruhr Economic Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
| 1992 | R&D Investment and International Productivity Differences In: NBER Working Papers. [Full Text][Citation analysis] | paper | 125 |
| 1993 | The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis In: NBER Working Papers. [Full Text][Citation analysis] | paper | 54 |
| 1996 | The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality In: NBER Working Papers. [Full Text][Citation analysis] | paper | 10 |
| 1996 | Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 1996 | International R&D Spillovers: A Re-Examination In: NBER Working Papers. [Full Text][Citation analysis] | paper | 59 |
| 1998 | Pharmaceutical Innovation, Mortality Reduction, and Economic Growth In: NBER Working Papers. [Full Text][Citation analysis] | paper | 24 |
| 2001 | The Effect of New Drugs on Mortality from Rare Diseases and HIV In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2002 | Benefits and Costs of Newer Drugs: An Update In: NBER Working Papers. [Full Text][Citation analysis] | paper | 15 |
| 2007 | Benefits and costs of newer drugs: an update.(2007) In: Managerial and Decision Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 15 | article | |
| 2002 | The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output In: NBER Working Papers. [Full Text][Citation analysis] | paper | 3 |
| 2002 | The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs In: NBER Working Papers. [Full Text][Citation analysis] | paper | 38 |
| 2002 | The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry In: NBER Working Papers. [Full Text][Citation analysis] | paper | 33 |
| 2002 | The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry.(2002) In: Journal of Law and Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 33 | article | |
| .() In: . [Full Text][Citation analysis] This paper has nother version. Agregated cites: 33 | paper | ||
| 2002 | Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as equipment for your health In: NBER Working Papers. [Full Text][Citation analysis] | paper | 14 |
| 2007 | Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as Equipment for Your Health.(2007) In: Managerial and Decision Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 14 | article | |
| 2003 | Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act In: NBER Working Papers. [Full Text][Citation analysis] | paper | 25 |
| 2002 | Using Patents Data to Map Technical Change in Health-Related Areas In: OECD Science, Technology and Industry Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2020 | The Health Impact of, and access to, New Drugs in Korea In: East Asian Economic Review. [Full Text][Citation analysis] | article | 0 |
| 2018 | The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the United States, 1999-2013 In: The American Economist. [Full Text][Citation analysis] | article | 0 |
| 2006 | Has Using Newer Drugs Reduced Admissions to Hospitals and Nursing Homes? In: Swiss Journal of Economics and Statistics (SJES). [Full Text][Citation analysis] | article | 0 |
| 2010 | Impact of Specialization on Health Outcomes – Evidence from U.S. Cancer Data In: SOI - Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2015 | The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010 In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2013 | The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007 In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2022 | The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017 In: Journal of Evolutionary Economics. [Full Text][Citation analysis] | article | 0 |
| 2017 | The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013 In: Latin American Economic Review. [Full Text][Citation analysis] | article | 0 |
| 2006 | The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003 In: PharmacoEconomics. [Full Text][Citation analysis] | article | 9 |
| 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7 In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
| 2022 | The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019 In: Swiss Journal of Economics and Statistics. [Full Text][Citation analysis] | article | 0 |
| 2009 | The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004 In: Economics of Innovation and New Technology. [Full Text][Citation analysis] | article | 5 |
| 2024 | The impact of biomedical innovation on the disability of elderly Medicare recipients, 2013–2019 In: Economics of Innovation and New Technology. [Full Text][Citation analysis] | article | 0 |
| 2011 | Has Pharmaceutical Innovation Reduced Social Security Disability Growth? In: International Journal of the Economics of Business. [Full Text][Citation analysis] | article | 0 |
| 1984 | Interindustry Technology Flows and Productivity Growth: A Re-examination. In: The Review of Economics and Statistics. [Full Text][Citation analysis] | article | 124 |
| 1987 | The Comparative Advantage of Educated Workers in Implementing New Technology. In: The Review of Economics and Statistics. [Full Text][Citation analysis] | article | 489 |
| 1988 | Estimation of the Internal Adjustment Costs Model Using Longitudinal Establishment Data. In: The Review of Economics and Statistics. [Full Text][Citation analysis] | article | 20 |
| 1994 | Testing the Convergence Hypothesis. In: The Review of Economics and Statistics. [Full Text][Citation analysis] | article | 89 |
| 2001 | Does Foreign Direct Investment Transfer Technology Across Borders? In: The Review of Economics and Statistics. [Full Text][Citation analysis] | article | 348 |
| 2001 | Does foreign direct investment transfer technology across borders?.(2001) In: ULB Institutional Repository. [Citation analysis] This paper has nother version. Agregated cites: 348 | paper | |
| 2014 | The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010 In: Journal of Human Capital. [Full Text][Citation analysis] | article | 1 |
| 1990 | The Effect of Ownership Changes on the Employment and Wages of Central Office and Other Personnel. In: Journal of Law and Economics. [Full Text][Citation analysis] | article | 49 |
| 2021 | Are drug prices subject to creative destruction? Evidence from the US, 1997–2017 In: Health Economics. [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team